Financial PerformanceResMed achieved better-than-expected results with 11% revenue growth and 34% EPS growth, indicating strong financial performance.
Long-Term StrategyThe company's 2030 Plan outlines a path towards high-single digit revenue growth with earnings growth above revenue growth, implying sustainable double-digit earnings growth is achievable.
Market Position And GrowthThe expansion of AirSense 11 rollout is contributing to ResMed gaining market share and enhancing its market position.